Two days later, the solution is cloudy, the stopper has been pierced half a dozen times, and nobody is sure how long it sat on the bench between draws
Convenient and VersatileEasy to mix and suitable for use before or after workouts, or as a high-protein snack throughout the day
Who is Retatrutide 40 mg for Retatrutide is an investigational drug (Phase 3), not yet approved by the FDA/EMA Triple GLP-1 / GIP / glucagon agonist a unique mechanism of action For patients for whom single (Ozempic) or dual (Mounjaro) agonists did not deliver enough effect Strictly under medical supervision Retatrutide 40 mg compared to other doses Retatrutide 12 mg showed ~24% weight loss over 48 weeks (Phase 2, NEJM 2023) Compared to Mounjaro 15 mg (~2226%) a similar effect, but with a triple mechanism Key difference: retatrutide activates the glucagon receptor, increasing energy expenditure No final Phase 3 results yet efficacy and safety are still being confirmed FAQ about Retatrutide 40 mg (ALLUVI) 1 ALLUVI Retatrutide injection pen (40 mg total, dial mechanism up to 10 mg per dose), 12 single-use ALLUVI needles and dosing instructions (Dosage Guide) with step-by-step schedule from 2.5 mg to 10 mg
Prim Care Companion CNS Disord 2025;27(3):24nr03855 Author affiliations are listed at the end of this article
To schedule with Amie or Desi, please call Rhiannon at 410.552.5050, extension 134
Why Empty Stomach Timing Matters If you choose to take it on an empty stomach, the general rule is to take it 30 minutes before a meal or two years after eating
